NovaBiotics, the clinical stage biotechnology company focused on the design and development of first-in-class anti-infectives for difficult-to-treat, medically unmet diseases, this morning announces its oral therapy for cystic fibrosis, Lynovex®, has met the study objectives of the CARE CF 1 clinical trial.
Oxford, UK, July 5 2018 - The state-of-the-art Schrödinger Building at The Oxford Science Park, one of the UK's leading parks for science and technology companies, is to be opened this afternoon by Sam Gyimah MP, Minister of State for Universities, Science, Research & Innovation.
Cambridge, UK., 3rd July 2018: Arecor Ltd (“the Company”), the UK-based leading formulation technology company, focussed on developing superior biopharmaceuticals and vaccines via its innovative formulation technology, continues to add to its strong patent portfolio protecting the Company’s proprietary Arestat™ technology and product assets.
EVONETIX LTD announced today that it had been awarded substantial funding to support the development of a novel enzymatic approach to DNA synthesis. Innovate UK, the UK’s innovation agency, will co-fund the £1.3 million project, which will be undertaken in collaboration with Durham University.
The RSA Group, a leading Life Sciences executive search firm, announced today that Darren Beckinsale has joined the firm as a Consultant. Darren will form part of the firm’s fast-growing Interims Practice.
Oxford, UK, June 20 2018 - Adaptix Imaging’s progress in developing a new generation of low radiation dose affordable medical scanners has been recognised at the 2018 Oxfordshire Business Awards, where it has won The Oxford Science Park Innovation Award.